These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27808579)

  • 1. Predictive and prognostic biomarkers in the era of new targeted therapies for chronic lymphocytic leukemia.
    Rossi D; Gerber B; Stüssi G
    Leuk Lymphoma; 2017 Jul; 58(7):1548-1560. PubMed ID: 27808579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapies for CLL: Practical issues with the changing treatment paradigm.
    Jain N; O'Brien S
    Blood Rev; 2016 May; 30(3):233-44. PubMed ID: 26776345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemia.
    Jacobs RW; Awan FT; Leslie LA; Usmani SZ; Ghosh N
    Expert Rev Hematol; 2016 Dec; 9(12):1177-1187. PubMed ID: 27791448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment.
    Hallek M
    Am J Hematol; 2019 Nov; 94(11):1266-1287. PubMed ID: 31364186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspectives on the role of chemotherapy in chronic lymphocytic leukemia.
    Wendtner CM; Gregor M
    Leuk Lymphoma; 2018 Feb; 59(2):300-310. PubMed ID: 28565930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Choose the Best Treatment and Testing for Chronic Lymphocytic Leukemia in the Tsunami of New Treatment Options.
    Yeung CCS; Shadman M
    Curr Oncol Rep; 2019 Jul; 21(8):74. PubMed ID: 31327069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia and infection risk in the era of targeted therapies: Linking mechanisms with infections.
    Hilal T; Gea-Banacloche JC; Leis JF
    Blood Rev; 2018 Sep; 32(5):387-399. PubMed ID: 29571669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balancing efficacy and toxicity of targeted agents currently used for the treatment of patients with chronic lymphocytic leukemia.
    Mauro FR; Caputo MD; Rosati S; Pepe S; De Benedittis D; De Luca ML; Foà R
    Expert Rev Hematol; 2018 Aug; 11(8):601-611. PubMed ID: 29969322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paving the way for new agents; is standard chemotherapy part of the treatment paradigm for chronic lymphocytic leukemia in the future?
    Frustaci AM; Montillo M; Picardi P; Mazzucchelli M; Cairoli R; Tedeschi A
    Expert Rev Hematol; 2016 Jul; 9(7):679-93. PubMed ID: 27253240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.
    Gaidano G; Rossi D
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):329-337. PubMed ID: 29222275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of Prognostic Factors in the Era of Targeted Therapies in CLL.
    Kittai AS; Lunning M; Danilov AV
    Curr Hematol Malig Rep; 2019 Aug; 14(4):302-309. PubMed ID: 31049852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing Patients With TP53-Deficient Chronic Lymphocytic Leukemia.
    Edelmann J; Gribben JG
    J Oncol Pract; 2017 Jun; 13(6):371-377. PubMed ID: 28605616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [State of the art molecular diagnostics and therapy of chronic lymphocytic leukaemia in the era of new targeted therapies].
    Gurbity Pálfi T; Fésüs V; Bödör C; Borbényi Z
    Orv Hetil; 2017 Oct; 158(41):1620-1629. PubMed ID: 29025288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Lymphocytic Leukemia: Diagnosis and Treatment.
    Strati P; Jain N; O'Brien S
    Mayo Clin Proc; 2018 May; 93(5):651-664. PubMed ID: 29728204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment algorithm for Japanese patients with chronic lymphocytic leukemia in the era of novel targeted therapies.
    Kojima K; Burger JA
    J Clin Exp Hematop; 2020 Dec; 60(4):130-137. PubMed ID: 32404571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Therapies in Chronic Lymphocytic Leukemia: A Rapidly Changing Landscape.
    Iovino L; Shadman M
    Curr Treat Options Oncol; 2020 Mar; 21(4):24. PubMed ID: 32170458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options.
    Sharma S; Rai KR
    Cancer; 2019 May; 125(9):1432-1440. PubMed ID: 30807655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on signal inhibitors in chronic lymphocytic leukemia.
    Boddu P; Jain N
    Clin Adv Hematol Oncol; 2018 Apr; 16(4):279-288. PubMed ID: 29742083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance Mechanisms to Targeted Agents in Chronic Lymphocytic Leukemia.
    Kittai AS; Woyach JA
    Cancer J; 2019; 25(6):428-435. PubMed ID: 31764124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Treatment of Chronic Lymphocytic Leukemia.
    Jamroziak K; Puła B; Walewski J
    Curr Treat Options Oncol; 2017 Jan; 18(1):5. PubMed ID: 28185174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.